Literature DB >> 14694210

Leptin expression in hypothalamic PVN reverses dietary obesity and hyperinsulinemia but stimulates ghrelin.

Michela Bagnasco1, Michael G Dube, Adi Katz, Pushpa S Kalra, Satya P Kalra.   

Abstract

OBJECTIVE: In order to circumvent the multiple peripheral effects of hyperleptinemia and leptin resistance, the efficacy of leptin transgene expression in the hypothalamic paraventricular nucleus (PVN) to reinstate the central energy homeostasis in obesity was examined. RESEARCH METHODS AND PROCEDURES: A recombinant adeno-associated viral vector encoding either leptin (rAAV-lep) or green fluorescent protein (rAAV-GFP) was microinjected into the PVN of obesity-prone rats consuming a high-fat diet (HFD).
RESULTS: rAAV-lep, and not rAAV-GFP, microinjection significantly reduced energy intake and enhanced energy expenditure, thereby resulting in normalization of weight and blood levels of leptin, insulin, free fatty acids, and glucose concomitant with enhanced ghrelin secretion during the extended period of observation. DISCUSSION: Thus, we show, for the first time, that amelioration of leptin insufficiency with enhanced localized leptin availability in the PVN alone can reverse dietary obesity and the attendant hyperinsulinemia and concurrently block the central stimulatory effects of elevated endogenous ghrelin on food intake and adiposity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14694210     DOI: 10.1038/oby.2003.196

Source DB:  PubMed          Journal:  Obes Res        ISSN: 1071-7323


  23 in total

Review 1.  To subjugate NPY is to improve the quality of life and live longer.

Authors:  Satya P Kalra; Pushpa S Kalra
Journal:  Peptides       Date:  2007-01-09       Impact factor: 3.750

2.  Inhibition of p66ShcA redox activity in cardiac muscle cells attenuates hyperglycemia-induced oxidative stress and apoptosis.

Authors:  Ashwani Malhotra; Himanshu Vashistha; Virendra S Yadav; Michael G Dube; Satya P Kalra; Maha Abdellatif; Leonard G Meggs
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-12-05       Impact factor: 4.733

Review 3.  Neuropeptide Y in normal eating and in genetic and dietary-induced obesity.

Authors:  B Beck
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-07-29       Impact factor: 6.237

Review 4.  Central insulin and leptin-mediated autonomic control of glucose homeostasis.

Authors:  Joseph S Marino; Yong Xu; Jennifer W Hill
Journal:  Trends Endocrinol Metab       Date:  2011-04-12       Impact factor: 12.015

5.  Reduction of high-fat diet-induced obesity after chronic administration of brain-derived neurotrophic factor in the hypothalamic ventromedial nucleus.

Authors:  R Godar; Y Dai; H Bainter; C Billington; C M Kotz; C F Wang
Journal:  Neuroscience       Date:  2011-08-05       Impact factor: 3.590

6.  Interactions of gastrointestinal peptides: ghrelin and its anorexigenic antagonists.

Authors:  Anna-Sophia Wisser; Piet Habbel; Bertram Wiedenmann; Burghard F Klapp; Hubert Mönnikes; Peter Kobelt
Journal:  Int J Pept       Date:  2010-01-06

7.  Body mass influences cortical bone mass independent of leptin signaling.

Authors:  U T Iwaniec; M G Dube; S Boghossian; H Song; W G Helferich; R T Turner; S P Kalra
Journal:  Bone       Date:  2008-11-27       Impact factor: 4.398

8.  Not insulin but insulin sensitivity, leptin, and cortisol are major factors regulating serum acylated ghrelin level in healthy women.

Authors:  A Kempa; B Krzyzanowska-Swiniarska; T Miazgowski; K Pilarska
Journal:  J Endocrinol Invest       Date:  2007-09       Impact factor: 4.256

9.  Leptin increases osteoblast-specific osteocalcin release through a hypothalamic relay.

Authors:  Satya P Kalra; Michael G Dube; Urszula T Iwaniec
Journal:  Peptides       Date:  2009-02-07       Impact factor: 3.750

Review 10.  Central leptin gene therapy ameliorates diabetes type 1 and 2 through two independent hypothalamic relays; a benefit beyond weight and appetite regulation.

Authors:  Satya P Kalra
Journal:  Peptides       Date:  2009-08-06       Impact factor: 3.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.